Clinical Trial Update: PLAY GAME: Post-concussion Syndrome in Youth - Assessing the GABAergic Effects of Melatonin [Phase 2, Phase 3]

View source ↗

Summary

A pediatric clinical trial update evaluating melatonin for potential GABAergic effects to address post-concussion symptoms, spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Concussion
• Post-concussion Syndrome
• Traumatic Brain Injury

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: University of Calgary | Conditions: Post-concussion Syndrome, Post-concussive Symptoms | Phase 2, Phase 3 | Status: UNKNOWN